251 related articles for article (PubMed ID: 8523528)
1. Foamy virus vectors.
Russell DW; Miller AD
J Virol; 1996 Jan; 70(1):217-22. PubMed ID: 8523528
[TBL] [Abstract][Full Text] [Related]
2. Transduction of hematopoietic cells by foamy virus vectors.
Hirata RK; Miller AD; Andrews RG; Russell DW
Blood; 1996 Nov; 88(9):3654-61. PubMed ID: 8896436
[TBL] [Abstract][Full Text] [Related]
3. Development of foamy virus vectors.
Vassilopoulos G; Josephson NC; Trobridge G
Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
[No Abstract] [Full Text] [Related]
4. Helper-free foamy virus vectors.
Trobridge GD; Russell DW
Hum Gene Ther; 1998 Nov; 9(17):2517-25. PubMed ID: 9853518
[TBL] [Abstract][Full Text] [Related]
5. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.
Lindemann D; Bock M; Schweizer M; Rethwilm A
J Virol; 1997 Jun; 71(6):4815-20. PubMed ID: 9151877
[TBL] [Abstract][Full Text] [Related]
6. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors.
Vassilopoulos G; Trobridge G; Josephson NC; Russell DW
Blood; 2001 Aug; 98(3):604-9. PubMed ID: 11468157
[TBL] [Abstract][Full Text] [Related]
8. Foamy virus vectors.
Mergia A; Heinkelein M
Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
[TBL] [Abstract][Full Text] [Related]
9. Cell-cycle dependence of foamy virus vectors.
Patton GS; Erlwein O; McClure MO
J Gen Virol; 2004 Oct; 85(Pt 10):2925-2930. PubMed ID: 15448354
[TBL] [Abstract][Full Text] [Related]
10. Efficient therapeutic gene expression in cultured rat hippocampal neurons mediated by human foamy virus vectors: a potential for the treatment of neurological diseases.
Liu W; He X; Cao Z; Sheng J; Liu H; Li Z; Li W
Intervirology; 2005; 48(5):329-35. PubMed ID: 15956801
[TBL] [Abstract][Full Text] [Related]
11. A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety.
Rigg RJ; Chen J; Dando JS; Forestell SP; Plavec I; Böhnlein E
Virology; 1996 Apr; 218(1):290-5. PubMed ID: 8615038
[TBL] [Abstract][Full Text] [Related]
12. Regulation of gene expression by human foamy virus and potentials of foamy viral vectors.
Bodem J; Löchelt M; Yang P; Flügel RM
Stem Cells; 1997; 15 Suppl 1():141-7. PubMed ID: 9368334
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes.
Liu W; Liu Z; Cao X; Cao Z; Xue L; Zhu F; He X; Li W
Mol Ther; 2007 Oct; 15(10):1834-41. PubMed ID: 17579580
[TBL] [Abstract][Full Text] [Related]
14. Study of human foamy virus proviral integration in chronically infected murine cells.
Neves M; Périès J; Saïb A
Res Virol; 1998; 149(6):393-401. PubMed ID: 9923015
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
[TBL] [Abstract][Full Text] [Related]
16. Sequences in pol are required for transfer of human foamy virus-based vectors.
Erlwein O; Bieniasz PD; McClure MO
J Virol; 1998 Jul; 72(7):5510-6. PubMed ID: 9621007
[TBL] [Abstract][Full Text] [Related]
17. Properties of human foamy virus relevant to its development as a vector for gene therapy.
Hill CL; Bieniasz PD; McClure MO
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2003-2009. PubMed ID: 10466797
[TBL] [Abstract][Full Text] [Related]
18. A new indicator cell line to monitor human foamy virus infection and stability in vitro.
Li Z; Yang P; Liu H; Li WX
Intervirology; 2002; 45(2):79-84. PubMed ID: 12145539
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.
Trobridge G; Russell DW
J Virol; 2004 Mar; 78(5):2327-35. PubMed ID: 14963129
[TBL] [Abstract][Full Text] [Related]
20. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
